Longitudinal Body Composition Assessment in Breast Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
About this trial
This observational cohort study aims to track longitudinal changes in body composition, including skeletal muscle mass and fat distribution, in patients diagnosed with breast cancer. Following primary surgery and adjuvant therapy, participants will be monitored over a 2-year period.
The primary objective is to evaluate the natural progression of skeletal muscle mass index (SMI) and metabolic changes in this population. By conducting serial measurements, this study seeks to characterize the longitudinal trends in muscle loss and body composition shifts post-treatment, providing data to better understand the physiological impact of the cancer recovery process.
Eligibility criteria
Qualifiers
>18 years of age
Diagnosed with stage I-III non-metastatic breast cancer within 12 months of diagnosis
Scheduled for surgery, chemotherapy, with or without radiotherapy or targeted therapy.
Disqualifiers
Women diagnosed with metastatic (stage IV) breast cancer
Women planning to move away from the area or be away for more than 6 months during the study period
Women planning to become pregnant during the study period
Implantable devices (e.g., pacemaker, nerve stimulator) or surgical implants (e.g., total hip or knee replacements)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov